Susanne Petri Selected Research

Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)

11/2022	Clinical trials in pediatric ALS: a TRICALS feasibility study.
9/2022	A SUMO4 initiator codon variant in amyotrophic lateral sclerosis reduces SUMO4 expression and alters stress granule dynamics.
1/2022	Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.
1/2022	Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS.
12/2021	Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
10/2021	Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.
3/2021	A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany.
1/2021	Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study.
10/2020	Knocking out C9ORF72 Exacerbates Axonal Trafficking Defects Associated with Hexanucleotide Repeat Expansion and Reduces Levels of Heat Shock Proteins.
1/2020	The upper cervical spinal cord in ALS assessed by cross-sectional and longitudinal 3T MRI.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanne Petri Research Topics

Disease

53	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2022 - 04/2004
13	Disease Progression 01/2022 - 11/2009
8	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 08/2006
6	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 12/2021 - 01/2020
6	Weight Loss (Weight Reduction) 11/2017 - 01/2005
5	Muscular Atrophy (Muscle Atrophy) 03/2021 - 04/2010
5	Gliosis 01/2019 - 04/2005
4	Respiratory Insufficiency (Respiratory Failure) 10/2021 - 03/2012
4	Inflammation (Inflammations) 01/2021 - 11/2009
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 07/2011
3	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2012
3	Body Weight (Weight, Body) 05/2015 - 01/2012
2	Fatigue 03/2021 - 01/2020
2	Dyspnea (Shortness of Breath) 01/2020 - 06/2019
2	Atrophy 01/2018 - 01/2016
2	Dysarthria (Spastic Dysarthria) 11/2017 - 01/2013
1	Craniocerebral Trauma (Head Injury) 09/2022
1	Neoplasms (Cancer) 09/2022
1	Headache (Headaches) 10/2021
1	Pain (Aches) 09/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2021
1	Muscle Weakness 01/2021
1	Hydrocephalus (Hydrocephaly) 01/2021
1	Central Nervous System Cavernous Hemangioma 12/2019
1	Sialorrhea 10/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Paresis (Hemiparesis) 05/2018
1	Hyperlipidemias (Hyperlipidemia) 05/2018
1	X-Linked Bulbo-Spinal Atrophy 05/2018
1	Deglutition Disorders (Dysphagia) 01/2018
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2018
1	Paraplegia (Spastic Paraplegia) 01/2018
1	Dyspepsia (Indigestion) 01/2017
1	Transitional Cell Carcinoma 01/2017
1	Stroke (Strokes) 01/2017

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
9	nusinersenIBA 03/2021 - 01/2020
8	Superoxide Dismutase-1IBA 01/2022 - 03/2006
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
5	Pharmaceutical PreparationsIBA 01/2022 - 05/2015
5	Neuroprotective AgentsIBA 05/2013 - 04/2006
4	Antisense OligonucleotidesIBA 03/2021 - 08/2020
3	AlbuminsIBA 01/2021 - 01/2019
3	Messenger RNA (mRNA)IBA 06/2010 - 04/2004
3	AntioxidantsIBA 04/2010 - 04/2006
2	chitotriosidaseIBA 01/2021 - 01/2021
2	incobotulinumtoxinA FDA Link 10/2019 - 01/2009
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2019 - 04/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2018
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2019 - 11/2011
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019 - 01/2019
2	ProgranulinsIBA 01/2018 - 02/2017
2	Riluzole FDA LinkGeneric 01/2018 - 11/2017
2	Histone Deacetylase InhibitorsIBA 06/2010 - 04/2006
2	Lenalidomide (CC 5013)FDA Link 11/2009 - 03/2006
1	Initiator Codon (Start Codon)IBA 09/2022
1	UbiquitinIBA 09/2022
1	EdaravoneIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 12/2021
1	TransketolaseIBA 12/2021
1	Simendan (Levosimendan)IBA 10/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	CreatinineIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Carisoprodol (Soma)FDA LinkGeneric 10/2020
1	salicylhydroxamic acid (SHAM)IBA 08/2020
1	GasesIBA 01/2020
1	Long Noncoding RNAIBA 12/2019
1	Serum AlbuminIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	CalciumIBA 01/2019
1	Neuropilin-1IBA 01/2019
1	Threonine (L-Threonine)FDA Link 11/2018
1	IronIBA 10/2018
1	AndrogensIBA 05/2018
1	Glucose (Dextrose)FDA LinkGeneric 05/2018
1	Dehydroepiandrosterone SulfateIBA 05/2018
1	Androgen Receptors (Androgen Receptor)IBA 05/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2018
1	NucleotidesIBA 01/2018
1	Monoamine Oxidase (MAO)IBA 01/2018
1	KinesinsIBA 01/2018
1	rasagiline (Azilect)FDA Link 01/2018
1	ozanezumabIBA 01/2017
1	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2016
1	Semaphorin-3AIBA 01/2016
1	OxidesIBA 05/2015
1	AntibodiesIBA 01/2015
1	GangliosidesIBA 01/2015
1	CytidineIBA 05/2013
1	Cytidine Diphosphate Choline (Citicoline)IBA 05/2013

Therapy/Procedure

12	Therapeutics 11/2022 - 01/2012
4	Gastrostomy 03/2018 - 03/2012
3	Noninvasive Ventilation 03/2021 - 06/2019
2	Spinal Injections 01/2019 - 01/2012
2	Enteral Nutrition (Feeding, Tube) 03/2018 - 01/2015
1	Chemoradiotherapy 09/2022
1	Intravenous Administration 01/2022
1	Denervation 01/2019